A team of researchers is designing a randomized controlled trial to evaluate a new oral anticoagulant compared to warfarin for the prevention of stroke in patients with atrial fibrillation. The investigators determine that they need a sample size of 2,000 patients to have an 80% probability of detecting a 15% relative risk reduction in stroke incidence, assuming a significance level () of 0.05. Due to funding constraints, the researchers are forced to decrease their sample size to 1,000 patients while keeping the significance level and the expected effect size constant. Which of the following statistical metrics will most likely increase as a direct result of this modification?
- AThe probability of committing a Type I error
- The probability of committing a Type II errorCevap
- CThe statistical power of the study
- DThe true effect size of the intervention
- EThe positive predictive value of the study results
Cevap
The probability of committing a Type II error
Decreasing the sample size reduces the statistical power of a study. Statistical power (often represented as ) is the probability of correctly rejecting a false null hypothesis. It is inversely related to the Type II error rate (), which is the probability of failing to detect a true difference. Therefore, a decrease in statistical power directly results in an increase in the probability of committing a Type II error.
Adım Adım Çözüm
Anahtar Kavram
Decreasing the sample size of a clinical trial decreases its statistical power, which consequently increases the probability of committing a Type II error ().